Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $66.01 USD
Change Today -1.48 / -2.19%
Volume 351.5K
PRXL On Other Exchanges
As of 1:35 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark A. Goldberg M.D.

President and Chief Operating Officer,PAREXEL International Corporation
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2014


Dr. Mark A. Goldberg, M.D., has been the President and Chief Operating Officer of PAREXEL International Corporation since July 1, 2012 and July 2008 respectively. Dr. Goldberg served as Chief Operating Officer of Parexel Informatics, Inc. He served in management capacities of increasing responsibility at Genzyme from 1996 to 2011, including as Senior Vice President for Clinical Development and Global Therapeutic Group Head for Oncology and Personalized Genetic Health. ...

Read Full Background

Corporate Headquarters*

195 West Street
Waltham, Massachusetts 02451

United States

Phone: 781-487-9900
Fax: 781-487-0525

Board Members Memberships*

There is no Board Members Memberships data available.


Bachelor's Degree
Massachusetts Institute of Technology
The University of Massachusetts Medical School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$570,000

Stock Options*

Restricted Stock Awards$512,610
All Other Compensation$15,936
Exercised Options37,728
Exercised Options Value$990,729
Exercisable Options65,622
Exercisable Options Value$1,776,232
Unexercisable Options75,950
Unexercisable Options Value$1,605,147
Total Value of Options$4,372,108
Total Number of Options179,300

Total Compensation*

Total Annual Cash Compensation$975,256
Total Short Term Compensation$570,000
Other Long Term Compensation$528,546
Total Calculated Compensation$2,006,300
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRXL:US $66.01 USD -1.48


Colin Shannon Chairman, Chief Executive Officer and President
PRA Health Sciences, Inc.
James C. Foster J.D.Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
Charles River Laboratories International, Inc.
Ciaran Murray Chief Executive Officer, Director and Chairman of Executive Committee
ICON Public Limited Company
Matthias Hartmann Chief Executive Officer and Member of Management Board
Ge Li Ph.D.Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee
WuXi PharmaTech (Cayman) Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PAREXEL INTERNATIONAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at